Newron Pharmaceuticals SpA - Company Profile
Powered by 
All the sales intelligence you need on Newron Pharmaceuticals SpA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Newron Pharmaceuticals SpA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Newron Pharmaceuticals SpA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Newron Pharmaceuticals SpA (Newron) develops novel therapies for diseases of the central nervous system (CNS) and pain. The company’s focus on R&D activities, lead product Xadago, and strategic alliances are its major strengths, whereas the Geographic Concentrationremains as an area of concern to the company. Its product pipeline, the market potential for pain, and market potential for Parkinson's disease provide ample opportunities for growth and gain a competitive advantage in the market. However, product liability claims, intense competition, and government regulations could affect the future business prospects of the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer